Fig. 5From: 1.5 T MR-guided and daily adapted SBRT for prostate cancer: feasibility, preliminary clinical tolerability, quality of life and patient-reported outcomes during treatmentPanel left: International Index of Erectile Function – 5 (IIEF-5). Panel right: International Consultation on Incontinence Questionnaire- Short Form (ICIQ-SF)Back to article page